Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New formulation of Botox: complete antibody-induced treatment failure in cervical dystonia.

× No keyword cloud information.

6 in total

1. Complete secondary botulinum toxin therapy failure in blepharospasm.

Authors: D Dressler
Journal: J Neurol Date: 2000-10 Impact factor: 4.849

2. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia.

Authors: J Jankovic; K D Vuong; J Ahsan
Journal: Neurology Date: 2003-04-08 Impact factor: 9.910

3. New formulation of BOTOX. Complete antibody-induced therapy failure in hemifacial spasm.

Authors: Dirk Dressler
Journal: J Neurol Date: 2004-03 Impact factor: 4.849

4. Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies--therapeutic consequences.

Authors: H Göschel; K Wohlfarth; J Frevert; R Dengler; H Bigalke
Journal: Exp Neurol Date: 1997-09 Impact factor: 5.330

5. Antibody-induced failure of botulinum toxin type B therapy in de novo patients.

Authors: Dirk Dressler; Hans Bigalke
Journal: Eur Neurol Date: 2004-10-12 Impact factor: 1.710

6. Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance.

Authors: M Zuber; M Sebald; N Bathien; J de Recondo; P Rondot
Journal: Neurology Date: 1993-09 Impact factor: 9.910

6 in total

7 in total

Review 1. Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity.

Authors: Christopher Dowson; Mohammad Shamim Khan; Prokar Dasgupta; Arun Sahai
Journal: Nat Rev Urol Date: 2010-12 Impact factor: 14.432

2. Botulinum toxin.

Authors: P K Nigam; Anjana Nigam
Journal: Indian J Dermatol Date: 2010 Impact factor: 1.494

3. Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?

Authors: Jürgen Frevert; Dirk Dressler
Journal: Biologics Date: 2010-12-09

4. Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products.

Authors: Jürgen Frevert
Journal: Drugs R D Date: 2015-03

5. Neurologic uses of botulinum neurotoxin type A.

Authors: John P Ney; Kevin R Joseph
Journal: Neuropsychiatr Dis Treat Date: 2007-12 Impact factor: 2.570

6. Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study.

Authors: Thomas Rappl; Daryousch Parvizi; Herwig Friedl; Maria Wiedner; Simone May; Bettina Kranzelbinder; Paul Wurzer; Bengt Hellbom
Journal: Clin Cosmet Investig Dermatol Date: 2013-09-24

7. Neurotoxin Impurities: A Review of Threats to Efficacy.

Authors: Je-Young Park; Owen Sunga; Rungsima Wanitphakdeedecha; Jürgen Frevert
Journal: Plast Reconstr Surg Glob Open Date: 2020-01-24

7 in total